Novolin
- Product NDC
- 64725-1837
- 11-digit product format
- 647251837
- Labeler code
- 64725
- Product ID
- 64725-1837_05dc7def-3137-4c5c-8d43-2baf9d7888df
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Human Insulin
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Labeler
- TYA Pharmaceuticals
- Application
- NDA019991
- Marketing category
- NDA
- Marketing start
- 1991-06-25
- Marketing end
- 0000-00-00
- Substance
- INSULIN HUMAN
- Active strength
- 100 [USP'U]/mL
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64725-1837-1 | Novolin 70/30 | 10 mL in 1 VIAL, GLASS | INJECTION, SUSPENSION | 10 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| METACRESOL | INACTIVE INGREDIENT | GGO4Y809LO | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| PHENOL | INACTIVE INGREDIENT | 339NCG44TV | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| PROTAMINE SULFATE | INACTIVE INGREDIENT | 0DE9724IHC | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INACTIVE INGREDIENT | 94255I6E2T | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
| ZINC CHLORIDE | INACTIVE INGREDIENT | 86Q357L16B | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64725-1837 | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [TYA PHARMACEUTICALS] | 2 | Legacy NDC, 1 package rows | 20140927_0cc57309-01ef-4a02-8d27-b981c768135a.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 311048 | insulin, human isophane / insulin regular 70/30 Injectable Suspension | PSN | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
| 213442 | NovoLIN 70/30 Injectable Suspension | PSN | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
| 213442 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin] | SBD | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
| 311048 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension | SCD | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
| 311048 | insulin, human mixed 70/30 100 UNT/ML Injectable Suspension | SY | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
| 213442 | Novolin 70/30 Injectable Suspension | SY | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
| 213442 | Relion Novolin 70/30 Injectable Suspension | SY | 0cc57309-01ef-4a02-8d27-b981c768135a | 2 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 64725-1837-1 | 64725183701 | 10 mL in 1 VIAL, GLASS | 10 ml | Historical |